First Trust Advisors
RVMD icon

First Trust Advisors’s Revolution Medicines RVMD Stock Holding History

First Trust Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5M Sell
26,694
-44,276
-62% -$6.47M ﹤0.01% 1590
2026
Q1 		$6.9M Buy
70,970
+31,605
+80% +$3.19M ﹤0.01% 1273
2025
Q4 		$3.14M Buy
+39,365
New +$2.58M ﹤0.01% 1667
2025
Q2 		– Sell
-16,865
Closed -$596K – 2696
2025
Q1 		$596K Sell
16,865
-103,055
-86% -$4.18M ﹤0.01% 2182
2024
Q4 		$5.25M Sell
119,920
-35,269
-23% -$1.78M ﹤0.01% 1334
2024
Q3 		$7.04M Buy
155,189
+48,346
+45% +$2.11M 0.01% 1179
2024
Q2 		$4.15M Buy
+106,843
New +$3.99M ﹤0.01% 1357
2024
Q1 		– Sell
-61,554
Closed -$1.77M – 2400
2023
Q4 		$1.77M Sell
61,554
-24,484
-28% -$588K ﹤0.01% 1774
2023
Q3 		$2.38M Buy
+86,038
New +$2.55M ﹤0.01% 1613
2023
Q2 		– Sell
-110,414
Closed -$2.39M – 2435
2023
Q1 		$2.39M Sell
110,414
-71,831
-39% -$1.77M ﹤0.01% 1608
2022
Q4 		$4.34M Buy
182,245
+167,859
+1,167% +$3.57M 0.01% 1270
2022
Q3 		$284K Buy
14,386
+1,091
+8% +$24K ﹤0.01% 2337
2022
Q2 		$259K Buy
+13,295
New +$259K ﹤0.01% 2335
2021
Q3 		– Sell
-12,387
Closed -$393K – 2618
2021
Q2 		$393K Sell
12,387
-212,354
-94% -$7.41M ﹤0.01% 2328
2021
Q1 		$10.3M Buy
224,741
+121,023
+117% +$5.43M 0.01% 925
2020
Q4 		$4.11M Buy
+103,718
New +$4.1M 0.01% 1179

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

First Trust Advisors's RVMD Position: Q2 2026 in Review

First Trust Advisors reduced its Revolution Medicines (RVMD) stake by 62% in Q2 2026, selling an estimated $6.47M and leaving 26,694 shares worth $5M. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

First Trust Advisors first reported a position in RVMD in Q4 2020 and has held it in 16 quarters since. The position peaked at $10.3M in Q1 2021. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • First Trust Advisors held 26,694 shares of Revolution Medicines worth $5M as of Q2 2026.
  • First Trust Advisors sold 44,276 Revolution Medicines shares in Q2 2026, an estimated $6.47M.
  • Revolution Medicines made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1590 holding.
  • First Trust Advisors first reported a position in Revolution Medicines in Q4 2020 and has held it in 16 quarters since.
  • First Trust Advisors's Revolution Medicines position peaked at $10.3M in Q1 2021.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.